This article or section needs to be wikified to meet Wikipedia's quality standards. Please help improve this article with relevant internal links. (June 2007)

Dr. Reddy's
Type	Public
Founded	1984
Headquarters	Hyderabad, Andhra Pradesh, India
Key people	Anji Reddy, Chairman Mr G. V. Prasad, CEO
Industry	Pharmaceuticals
Revenue	$1.5 Billion (MAY2007)
Net income	$216 Million (MAY2007)
Employees	7,525
Website	www.drreddys.com

Dr. Reddy’s Laboratories Ltd. (Reddy's), founded in 1984 by Dr. K. Anji Reddy, has become India’s third biggest pharmaceutical company. Reddy had worked in the publicly-owned Indian Drugs and Pharmaceuticals Ltd. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company more than 190 medications ready for patients to take, 60 active pharmaceutical ingredients, for drug manufacture, diagnostic kits, critical care and biotechnology products. Image File history File links Wikitext. ... This article does not cite any references or sources. ... Image File history File links Flag_of_India. ... Hyderabad   or Haydarābād // ( Urdu:حیدر آباد), (Telugu:హైదరాబాదు) is the capital city of the Indian state of Andhra Pradesh. ... Andhra redirects here. ... Image File history File links Flag_of_India. ... Dr Anji Reddy holds a Ph. ... Image File history File links Flag_of_India. ... Pharmacology (in Greek: pharmacon is drug, and logos is science) is the study of how chemical substances interfere with living systems. ... For the tax agency in Ireland of the same name, see Revenue Commissioners. ... Net income is equal to the income that a firm has after subtracting costs and expenses from the total revenue. ... This article is about work. ... A website (alternatively, Web site or web site) is a collection of Web pages, images, videos or other digital assets that is hosted on one or several Web server(s), usually accessible via the Internet, cell phone or a LAN. A Web page is a document, typically written in HTML... Dr Anji Reddy holds a Ph. ... API may refer to: In computing, application programming interface In petroleum industry, American Petroleum Institute In education, Academic Performance Index This page concerning a three-letter acronym or abbreviation is a disambiguation page — a navigational aid which lists other pages that might otherwise share the same title. ...

Reddy’s began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets – that had the advantage of not spend time and money on a manufacturing plant that that would gain approval from a drug licensing body such as the US’s Food and Drug Administration. Much of Reddy’s early success came in those unregulated markets, where process patents – not product patents – are recognized. With that money in the bank, the company could reverse-engineer patented drugs from more developed countries and sell them royalty-free in India and Russia. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. For other uses of terms redirecting here, see US (disambiguation), USA (disambiguation), and United States (disambiguation) Motto In God We Trust(since 1956) (From Many, One; Latin, traditional) Anthem The Star-Spangled Banner Capital Washington, D.C. Largest city New York City National language English (de facto)1 Demonym American... “FDA” redirects here. ... For other uses of terms redirecting here, see US (disambiguation), USA (disambiguation), and United States (disambiguation) Motto In God We Trust(since 1956) (From Many, One; Latin, traditional) Anthem The Star-Spangled Banner Capital Washington, D.C. Largest city New York City National language English (de facto)1 Demonym American... For other uses, see Europe (disambiguation). ...

By 2007, Reddy’s had six FDA-plants producing active pharmaceutical ingredients in India and seven FDA-inspected and ISO 9001 (quality) and ISO 14001 (environmental management) certified plants making patient-ready medications – five of them in India and two in the UK.^[1] The United States Food and Drug Administration is the government agency responsible for regulating food, dietary supplements, drugs, cosmetics, medical devices, biologics and blood products in the United States. ... The United States Food and Drug Administration is the government agency responsible for regulating food, dietary supplements, drugs, cosmetics, medical devices, biologics and blood products in the United States. ... ISO 9000 specifies requirements for a Quality Management System overseeing the production of a product or service. ... The ISO 14000 environmental management standards exist to ensure products and services have the lowest possible environmental impact. ...

Dr Reddy's and regulations

Generics Goldmine

With drug prices high in most OECD member states, health services came to rely on generic versions of drugs rather than the branded ‘originals’ – in the UK this was made the result of advice to National Health Service doctors from the country’s health department by a and in the US the 1984 Hatch-Waxman Act or Drug Price Competition and Patent Term Restoration Act^[2] and the financial liberalization of the mid 1990s^[3] gave what had been ‘third world’ pharmaceuticals firms a chance of getting into more lucrative markets, using their ability to reverse-engineer. In 1997, the U.S. FDA created an incentive for generics companies to engage branded drug makers in court, with the introduction of the Para 4 filing law, in a bid to generate competition. The law rewarded generic manufacturers for challenging existing patents instead of waiting for them to expire. The Organisation for Economic Co-operation and Development (OECD), (in French: Organisation de coopération et de développement économiques; OCDE) is an international organisation of those developed countries that accept the principles of representative democracy and a free market economy. ... A generic drug (pl. ... NHS redirects here. ... The Department of Health headquarters in Whitehall The Department of Health is a department of the United Kingdom government. ... The Hatch-Waxman Act is the informal name of a 1984 U.S. Federal law called the Drug Price Competition and Patent Term Restoration Act, which established the modern system of generic drugs. ... The Drug Price Competition and Patent Term Restoration Act, informally known as the Hatch-Waxman Act [Public Law 98-417], is a 1984 United States federal law which established the modern system of generic drugs. ...

India: Patents and Profits

In the 60 years since India’s independence, the domestic pharmaceutical industry has been shaped primarily by regulation. Initially, multinationals had a near monopoly on pharmaceuticals. They imported and marketed complete formulations in India, mainly low-cost generics along with a few highly priced speciality drugs. When the government increased pressure to deter the import of finished products, multinationals set up formulating units and continued importing bulk drugs. A multinational corporation (or transnational corporation) (MNC/TNC) is a corporation or enterprise that manages production establishments or delivers services in at least two countries. ... A multinational corporation (or transnational corporation) (MNC/TNC) is a corporation or enterprise that manages production establishments or delivers services in at least two countries. ...

In the 1960s, the Indian government laid the foundation for a domestic pharmaceuticals industry by promoting the state-owned Hindustan Antibiotics Ltd. and Indian Drugs and Pharmaceuticals Ltd. for the manufacture of bulk drugs. However, the multinationals maintained their lead because of their technical expertise, financial muscle, and ability to move innovations from one market to another. The high cost of original research, the sophisticated scientific knowledge needed and a lack of financing options worked against the private-sector Indian companies.

This state of affairs changed with the 1970 Indian Patent Act, whereby substances used in foods and pharmaceuticals were not granted product patents. Process patents were granted for a period of five years from the date of grant or seven years from the date of filing, whichever was earlier. Process modifications were easier to accomplish, and there was a rapid influx of domestic manufacturers. These companies generally started with bulk drugs and gradually progressed into complete medications. The multinationals were constrained by their parent companies’ product ranges but the Indian producers could make almost anything. Not paying product patent royalties cut the cost of local manufacture and helped Indian producers thrive. A Patent Act is a countrys legislation that controls the use of patents. ...

Shortly thereafter, the Drugs Price Control Order put a ceiling on prices of certain mass-usage formulations. Since selling at such low prices could cause discontent in their home markets, multinationals dramatically curtailed new product launches, further boosting India's domestic players.

Under the Foreign Exchange Regulations Act' in the late 1970s, the multinationals had to reduce their stakes in Indian ventures to 40%, or comply with certain export obligations and keep their equity stake at 51%. Many multinationals preferred not to business in that climate – another shot in the arm for India's pharmaceutical industry. Federal Emergency Relief Administration (FERA) was the committee established as a result of Federal Emergency Relief Act. ...

In 1986, Reddy’s started operations on branded formulations. Within a year Reddy’s had launched Norilet, Reddy’s first recognized brand in India. But, thanks to its superior process technology, Reddy’s scored a big success with Omez, its branded omezaprole – ulcer and reflux oesophagitis medication – launched at half the price of other brands on the Indian market at that time.

Within a year, Reddy’s became the first Indian company to export the active ingredients for pharmaceuticals to Europe. In 1987, Reddy's started to transform itself from a supplier of pharmaceutical ingredients to other manufacturers into a manufacturer of pharmaceutical products.

The passage from India

First it moved into Russia, forming a joint venture with the country’s biggest pharmaceuticals producer Biomed in 1992, pulling out in 1995 amid accusations of scandal, involving 'a significant material loss due to the activities of Moscow's branch of Reddy's Labs with the help of Biomed’s chief executive^[4] selling the joint venture to the Kremlin-friendly Sistema group and buying the whole company in 2002.

In 1993, Reddy’s entered into a joint venture in the Middle East and created two formulation units there and in Russia. Reddy’s exported bulk drugs to these formulation units, which then converted them into finished products. In 1994, Reddy’s started targeting the US generic market by building state of art manufacturing facility. A map showing countries commonly considered to be part of the Middle East The Middle East is a region comprising the lands around the southern and eastern parts of the Mediterranean Sea, a territory that extends from the eastern Mediterranean Sea to the Persian Gulf. ...

Reddy’s path into new drug discovery involved targeting speciality generics products in western markets to gain drug discovery abilities. The reason why development of speciality drugs was an important link to the development of new chemical entities is that all the elements that are involved in a NCE effort, such as innovation in the laboratory, developing the compound, sending the sales team to the market etc. are also stages in the development of a specialty drug. Reddy’s also invested heavily in building R&D labs and is the only Indian company to have significant R&D being undertaken overseas. Dr. Reddy’s Research Foundation was established in 1992 and dedicated to research in area of new drug discovery. At first, the foundation’s drug research strategy revolved around searching for analogues but its changed focus to innovative R&D, hiring new scientists – especially Indian students studying abroad on doctoral and post-doctoral courses. In 2000, foundation set up a US lab in Atlanta, dedicated to discovery and design of novel therapeutics. The lab is called Reddy US Therapeutics Inc (RUSTI) and its main aim is the discovery of next-generation drugs using genomics and proteomics. Reddy’s research thrust focused on large niche areas in western markets – anti-cancer, anti-diabetes, cardiovascular and anti-infection drugs. For other uses of terms redirecting here, see US (disambiguation), USA (disambiguation), and United States (disambiguation) Motto In God We Trust(since 1956) (From Many, One; Latin, traditional) Anthem The Star-Spangled Banner Capital Washington, D.C. Largest city New York City National language English (de facto)1 Demonym American... This article is about the state capital of Georgia. ... Genomics is the study of an organisms entire genome; Rathore et al, . Investigation of single genes, their functions and roles is something very common in todays medical and biological research, and cannot be said to be genomics but rather the most typical feature of molecular biology. ... For the journal Proteomics, see Proteomics (journal). ... Cancer is a class of diseases or disorders characterized by uncontrolled division of cells and the ability of these to spread, either by direct growth into adjacent tissue through invasion, or by implantation into distant sites by metastasis (where cancer cells are transported through the bloodstream or lymphatic system). ... This article is about the disease that features high blood sugar. ... The circulatory system or cardiovascular system is the organ system which circulates blood around the body of most animals. ...

Reddy’s international marketing successes were built on a strong manufacturing base which itself was a result of inorganic growth through acquisition of international and national facilities. Reddy’s merged Cheminor Drug Limited (CDL) with primary aim of supplying APIs to the technically demanding markets of North America and Europe. This merger also gave Reddy’s entry into value added generics business in the regulated markets of APIs. North America North America is a continent[1] in the Earths northern hemisphere and (chiefly) western hemisphere. ... For other uses, see Europe (disambiguation). ...

By 1997, Reddy’s was ready for the next major step. From being an API and bulk drug supplier to regulated markets like the USA and the UK, and a branded formulations supplier in unregulated markets like India and Russia, Reddy’s made the transition into generics by filing an Abbreviated New Drug Application (ANDA) in the USA. The same year, Reddy’s out-licensed a molecule for clinical trials to Novo Nordisk, a Danish pharmaceutical company. Anda is the name of two places in the Philippines: Anda, Bohol Anda, Pangasinan Anda is a location in Afghanistan Anda is a small island in Norway, home to the Anda lighthouse. ... Novo Nordisk (OMX: NOVO B, NYSE: NVO) manufactures and markets pharmaceutical products and services. ...

It strengthened its Indian manufacturing operations by acquiring American Remedies Ltd. in 1999. This acquisition made Reddy’s the third largest pharmaceutical company in India, after Ranbaxy and Glaxo (I) Ltd., with a full spectrum of pharmaceutical products, which included bulk drugs, intermediates, finished dosages, chemical synthesis, diagnostics and biotechnology. Ranbaxy Laboratories Limited is an Indian company incorporated in 1961. ... GlaxoSmithKline (GSK) plc is a pharmaceutical and healthcare company, one of the largest in the world. ...

Reddy’s started exploiting Para 4 filing as a strategy in bringing new drugs to the market at a faster pace. In 1999 it submitted a Para 4 application for Omeprazole- the drug it had so successfully marketed in India. In December 2000, Reddy’s had undertaken its first commercial launch of a generic product in the USA., and its first product with market exclusivity was launched there in August 2001. The same year, it also became the first non-Japanese pharmaceutical company from the Asia-Pacific region to obtain an NYSE listing. Each of these achievements was path breaking for the Indian pharmaceutical industry. Omeprazole (INN) (IPA: ) is a proton pump inhibitor used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome. ... Map showing general definition of Asia-Pacific The term Asia-Pacific generally applies to littoral East Asia, Southeast Asia and Australasia near the Pacific Ocean, plus the states in the ocean itself (Oceania). ... New York Stock Exchange (June 2003) The New York Stock Exchange (NYSE) is one of the largest stock exchanges in the world. ...

In 2001 when Reddy’s became the first Indian company to launch the generic drug, fluoxetine (a generic version of Eli Lilly’s Prozac) with 180 day market exclusivity in the USA. Eli Lilly's antidepressant drug Prozac had sales in excess of $1 billion per year in the late nineties. Barr Laboratories of the U.S. obtained exclusivity for all of the approved dosage forms (10mg, 20mg) except one (40mg), which was obtained by Reddy’s. Lilly had numerous other patents surrounding the drug compound and had already enjoyed a long period of patent protection. The case was heard twice by the Federal Circuit court, and Reddy’s won both hearings. The importance of market exclusivity is illustrated by the fact that. Reddy’s generated nearly $70 million in revenue during the six-month period. With such phenomenal returns at stake, Reddy’s was beginning to gamble on litigation that could cost millions of dollars, depending on the length of the trial. Prozac redirects here. ... One of the worlds largest corporations, Eli Lilly and Company (NYSE: LLY) is a global pharmaceutical company with headquarters in Indianapolis,Indiana, USA. A Fortune 500 corporation, the company had revenues of $12. ... Background Fluoxetine hydrochloride (brand names include Prozac®, Symbyax® (compounded with olanzapine), Sarafem®, Fontex® (Sweden), Fluctine (Austria, Germany), Prodep (India), Fludac (India)) is an antidepressant drug used medically in the treatment of depression, obsessive-compulsive disorder, bulimia nervosa, premenstrual dysphoric disorder, and many other disorders. ... Barr Pharmaceuticals (NYSE: BRL) is a specialty pharmaceutical company based in Wood Cliff Lakes, New Jersey, that develops, makes, and sells generic and proprietary prescription pharmaceuticals. ...

The fluoxetinemarketing success was followed by the launch of ibuprofen tablets 400, 600 and 800 mg in the US under its own brand name, in January 2003. Direct marketing under the Reddy’s brand name represented a significant step in the company’s efforts to build a strong and sustainable US generic business. It was the first step in building Reddy’s fully fledged distribution network in the US market. This was much on the lines of the Indian software majors who have marketing professionals in the US. Ibuprofen (INN) (IPA: ) (from the earlier nomenclature iso-butyl-propanoic-phenolic acid) is a non-steroidal anti-inflammatory drug (NSAID) originally marketed as Nurofen and since under various trademarks, including Act-3, Advil, Brufen, Dorival, Herron Blue, Panafen, Motrin, Nuprin and Burana (Finland), Ipren or Ibumetin (Denmark and Sweden), Ibuprom... Year 2003 (MMIII) was a common year starting on Wednesday of the Gregorian calendar. ... For other uses of terms redirecting here, see US (disambiguation), USA (disambiguation), and United States (disambiguation) Motto In God We Trust(since 1956) (From Many, One; Latin, traditional) Anthem The Star-Spangled Banner Capital Washington, D.C. Largest city New York City National language English (de facto)1 Demonym American...

In 2001 Reddy’s completed its US initial public offering of $132.8 million American Depositary Receipts issue and also listed on the New York Stock exchange. Funds raided from the US initial public offering helped Reddy’s move into international production – and take over technology-based companies. An American Depositary Receipt (ADR) is how the stock of most foreign companies trades in United States stock markets. ... This article is about the state. ... “IPO” redirects here. ...

In 2002, Reddy’s started its European operations by acquiring two pharmaceutical firms in the UK. The acquisition of BMS Laboratories and its wholly owned subsidiary, Meridian UK allowed Reddy’s to expand geographically and gave company an opportunity to enter the European market. In 2003 Reddy’s also invested US$. 5.25 million in equity capital of Bio Sciences ltd.

Auriegene Discovery Technologies, a contract research company was established as a fully owned subsidiary of Reddy’s in 2002, to gain experience of drug discovery through contract research for other Pharma companies. Reddy’s entered into a venture investment type of agreement with the Indian bank, ICICI. Under the terms of the agreement, ICICI Venture funds the development, registration and legal costs related to the commercialization of ANDAs on a pre-determined basis. On commercialization of these products, Dr. Reddy's pays ICICI Venture royalty on net sales for a period of 5 years. Reddy’s successful growth into a fully integrated pharmaceutical company in less than a decade was founded on a successful and targeted program of inorganic growth and investments in process R&D. It had chosen a high risk-high gain strategy to growth by going into direct competition with existing patent holders. A major challenge for Reddy’s is to find ways to de-risk its overall strategy. One way may lie in managing the cash flows from the ‘safer’ API and formulations businesses. Another way may be to seek out more experienced partners for the R&D business or use acquisitions to boost R&D resources and revenues. It has chosen the global route and went on an acquiring spree. ICICI Bank (formerly Industrial Credit and Investment Corporation of India) is Indias largest private bank and also the largest bank in the country. ...

In March 2002, Dr. Reddy’s acquired BMS Laboratories, Beverley, and it is wholly owned subsidiary Meridian Healthcare, for EUR 14.81 million. These companies deal in oral solids, liquids and packaging, with manufacturing facilities in London and Beverley in the UK. Recently, Dr. Reddy’s entered into an R&D and commercialization agreement with Argenta Discovery Ltd., a private drug development company based in the UK, for the treatment of COPD. Arms of Beverley For other uses, see Beverley (disambiguation). ... This article is about the capital of England and the United Kingdom. ... Arms of Beverley For other uses, see Beverley (disambiguation). ...

With growing success in the generics market, Reddy’s also came to realize the need for developing marketing and distribution capabilities in the USA Reddy’s was considering several options for marketing the hypertension product in 2003. The company already had one tie-up with Pharmaceutical Resources, Inc. to market Fluoxentine 40 mg tablets. It also had a tie-up with Par Pharmaceuticals Inc., to produce and market over-the-counter drugs in the U.S. In addition to the United States, Reddy’s generics business had established a presence in the U.K., is a platform for expansion into other countries in Europe. Reddy’s also plans to expand its presence in Canada and South Africa. Its API business had sales in over 60 countries, with the US and India being the most significant revenue contributors. The branded formulations business was active in over 30 countries and Reddy’s was a significant player in the Indian and Russian markets. The business planned to significantly increase its presence in China, Brazil and Mexico in the near future. For other forms of hypertension, see Hypertension (disambiguation). ...

Dr. Reddy’s entered into a 10-year agreement with Rheoscience A/S of Denmark for the joint development and commercialization of Balaglitazone (DRF-2593), a molecule for the treatment of type-2 diabetes. Rheoscience holds this product’s marketing rights for the EU and China, while the rights for the US and the rest of the world will be held by Dr. Reddy’s. Dr. Reddy’s conducted clinical trials of its cardiovascular drug RUS 3108 in Belfast, Northern Ireland, in 2005.The trials were conducted to study the safety and the pharmacokinetic profiles of the drug, which is intended for the treatment of atherosclerosis, a major cause of cardiovascular disorders. This article is about the disease that features high blood sugar. ... This article is about the city in Northern Ireland. ... Northern Ireland (Irish: , Ulster Scots: Norlin Airlann) is a constituent country of the United Kingdom lying in the northeast of the island of Ireland, covering 5,459 square miles (14,139 km², about a sixth of the islands total area). ...

Dr. Reddy’s entered into a marketing agreement with Eurodrug Laboratories, a pharmaceutical company based in Netherlands, for improving its product portfolio for respiratory diseases. It introduced a second-generation xanthine bronchodilator, Doxofylline, which is used for the treatment of asthma and chronic obstructive pulmonary disease (COPD) patients.

In 2004, Reddy’s acquired Trigenesis Therapeutics Inc; the US based private dermatology company. This acquisition gave Reddy’s access to certain products and proprietary technologies in dermatology segment. Dr. Reddy’s Para 4 application strategy for generic business received a severe set back when Reddy’s lost the patent challenge in case of Pfizer’s drug Norvasc (amlodipine maleate). Amlodipine maleate, the generic version of Pfizer's Norvasc, is indicated for the treatment of hypertension and angina. The cost involved in patent litigation as well as the strategic reversal affected Reddy’s plans to start speciality business in the US generic markets. Dermatology (from Greek δερμα, skin) is a branch of medicine dealing with the skin and its appendages (hair, sweat glands, etc). ... Pfizer Incorporated (NYSE: PFE) is the worlds largest research-based pharmaceutical company[1].[1] The company is based in New York City. ... See amlodipine. ... Amlodipine (as besylate, mesylate or maleate) is a long-acting calcium channel blocker (dihydropyridine) used as an anti-hypertensive and in the treatment of angina. ... Pfizer Incorporated (NYSE: PFE) is the worlds largest research-based pharmaceutical company[1].[1] The company is based in New York City. ... See amlodipine. ... For other forms of hypertension, see Hypertension (disambiguation). ... angina tonsillaris see tonsillitis. ...

In March 2006, Dr. Reddy’s acquired Betapharm Arzneimittel GmbH from 3i for EUR 480 million. This is one of the largest-ever foreign acquisitions by an Indian pharmaceutical company. Betapharm is Germany’s fourth-largest generics pharmaceuticals covering 3.5% market share including 150 active pharmaceutical ingredients.

Reddy’s has promoted India’s first integrated drug development company Perlecan Pharma Pvt Ltd together with ICICI ventures capital fund management company Ltd and Citigroup Venture Capital International growth partnership Mauritius Ltd. The combined entity will undertake clinical development and out-licensing of New Chemical Entity Assets. Citigroup Inc. ...

Dr. Reddy's is presently licensed by Merck & Co. to sell an authorized generic version of the popular drug simvastatin (Zocor) in the USA. Since Dr. Reddy's has a license from Merck, it is not subject to the exclusivity period on generic simvastatin of 180 days from June 23, 2006, which is split between Ranbaxy Laboratories (also from India) and Teva Pharmaceutical Industries. Merck & Co. ... Simvastatin (INN) (IPA: ) is a hypolipidemic drug belonging to the class of pharmaceuticals called statins. It is used to control hypercholesterolemia (elevated cholesterol levels) and to prevent cardiovascular disease. ... In pharmacology, simvastatin (Zocor®, Zocor Heart Pro®, marketed by the pharmaceutical company Merck & Co. ... Ranbaxy Laboratories Limited is an Indian company incorporated in 1961. ... Teva Pharmaceutical Industries Ltd. ...

As on 2006, Dr. Reddy’s Labs crossed US $500 M in revenues flowing from segments such as APIs, Branded Formulations and Generics with the former two segments accounting for almost 75% of revenues. On an overall note, Dr. Reddy’s controls the entire supply chain and offers high-quality products at competitive prices at the opportune time. It deals in and manages all the processes, from the development of the API to the submission of finished dosage dossiers to the regulatory agencies. It has moved from strength to strength and has built a variety of partnerships as well as acquisitions across its key overseas markets, US and Europe and had laid a strong foundation and is well poised to take advantage of opportunities in international markets.

Key people

On March 31, 2006 board members and senior executives included.

• Dr. K Anji Reddy - chairman
• Mr. G V Prasad - vice chairman & chief executive
• Mr. Satish Reddy - managing director & COO
• Mr. Anupam Puri - independent director
• Dr. Krishna G Palepu - independent director
• Dr. Omkar Goswami - independent director
• Mr. P N Devarajan - independent director
• Mr. Ravi Bhoothalingam - independent director
• Dr. V. Mohan - independent director
• Dr. Rajinder Kumar - president, Research, Development and Commercialization (joined on April 30 2007)^[5]

Dr Anji Reddy holds a Ph. ... Chief Executive Officer (CEO) is the job of having the ultimate executive responsibility or authority within an organization or corporation. ...

Key products

Top-15 active pharmaceutical ingredients

• Ciprofloxacin Hydrochloride
• Ramipril
• Terbinafine HCI
• Ibuprofen
• Sertaline Hydrochloride
• Ranitidine HCI Form 2
• Naproxen Sodium
• Naproxen
• Atorvastatin
• Montelukast
• Losartan Potassium
• Sparfloxacin
• Nizatidine
• Ranitidine Hydrochloride Form 1
• Clopidogrel (Not in US due to 2007 patent case)

Ciprofloxacin is the generic international name for the synthetic antibiotic manufactured and sold by Bayer Pharmaceutical under the brand names Cipro®, Ciproxin® and Ciprobay® (and other brand names in other markets, e. ... Ramipril (marketed as Tritace or Altace) is an angiotensin-converting enzyme (ACE) inhibitor, used to treat hypertension and congestive heart failure. ... Terbinafine hydrochloride (Lamisil® in UK & US) is a synthetic allylamine antifungal. ... Ibuprofen (INN) (IPA: ) (from the earlier nomenclature iso-butyl-propanoic-phenolic acid) is a non-steroidal anti-inflammatory drug (NSAID) originally marketed as Nurofen and since under various trademarks, including Act-3, Advil, Brufen, Dorival, Herron Blue, Panafen, Motrin, Nuprin and Burana (Finland), Ipren or Ibumetin (Denmark and Sweden), Ibuprom... “Lustral” redirects here. ... Ranitidine (INN) (IPA: ) is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). ... Naproxen (trade names: Aleve, Anaprox, Naprosyn, Naprelan) is a non-steroidal anti-inflammatory drug commonly used for the reduction of mild to moderate pain, fever, inflammation and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, injury, menstrual cramps, tendinitis, bursitis, and the treatment of... Naproxen (INN) (IPA: ) is a non-steroidal anti-inflammatory drug (NSAID) commonly used for the reduction of mild to moderate pain, fever, inflammation and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, psoriatic arthritis, gout, ankylosing spondylitis, injury (like fractures), menstrual cramps, tendonitis, bursitis, and the treatment of primary... Atorvastatin (INN) (IPA: ) is a member of the drug class known as statins, used for lowering cholesterol and thereby reducing cardiovascular disease. ... Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. ... Losartan (rINN) (IPA: ) is an angiotensin II receptor antagonist drug used mainly to treat high blood pressure (hypertension). ... Sparfloxacin (spar FLOX a sin), trade names Zagam® and Zagam Respipac, is a fluoroquinolone antibiotic used in the treatment of bacterial infections. ... Nizatidine is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). ... Ranitidine (INN) (IPA: ) is a histamine H2-receptor antagonist that inhibits stomach acid production, and commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). ... A box of Plavix Clopidogrel is a potent oral antiplatelet agent often used in the treatment of coronary artery disease, peripheral vascular disease, and cerebrovascular disease. ...

Top-10 brands in India

• Omez
• Nise
• Stamlo
• Stamlo Beta
• Enam
• Atocor
• Razo
• Reclimet
• Clamp
• Mintop

External links

• Official website
• Dr. Reddy’s receive exclusive rights for Zocor
• [1]
• [2]
• [3]
• [4]
• Pharmaceutical Jobs in Dr. Reddy’s
• Drug Discovery and Development in Dr. Reddy’s

References

v • d • e BSE Sensex companies of India
ACC · Bajaj · Airtel · BHEL · Cipla · DLF · Grasim · Gujarat Ambuja · HDFC · HDFC Bank · Hero Honda · Hindalco · HUL (formerly HLL) · ICICI Bank · Infosys · ITC · L&T · Maruti · NTPC · ONGC · Ranbaxy · Reliance Comm. · Reliance Energy · RIL · Satyam · SBI · TCS · Tata Motors · Tata Steel · Wipro Image File history File links Flag_of_India. ... The Bombay Stock Exchange The BSE Sensex or Bombay Stock Exchange Sensitive Index is a value-weighted index composed of 30 stocks with the base April 1979 = 100. ... The Associated Cement Companies Limited(ACC), an Indian company in cement manufacturing business. ... Bajaj Auto is a major Indian automobile manufacturer. ... For the information technology, see Airtel (FBI). ... BHEL or Bharat Heavy Electricals Limited is a Gas and Steam turbine manufacturer in India. ... Cipla is an Indian pharmaceutical company, best-known for manufacturing cheap anti-AIDS drugs. ... DLF Universal Limited, or DLF, is Indias largest real estate developer based in New Delhi. ... // Aditya Birla Group operates over 40 companies in 12 countries across 4 continents. ... Ambuja Cements Limited, formerly known as Gujrat Ambuja Limited is a major Cement producing company in India. ... HDFC or Housing Development Finance Corporation Limited, founded 1977 by Hasmukhbhai Parekh, is an Indian company which is primarily in the business of providing home loans. ... HDFC Bank logo HDFC Bank (NYSE: HDB), one amongst the firsts of the new generation, tech-savvy commercial banks of India, was set up in august 1994 after the Reserve Bank of India allowed setting up of Banks in the private sector. ... Hero Honda Motors Ltd is the Worlds largest manufacturer of motorcycles (by quantity). ... Hindalco Industries is one of Indias largest material-related company and is a subsidiary of the Aditya Birla Group. ... Hindustan Unilever Limited (abbreviated to HUL), formerly Hindustan Lever Limited , is Indias largest consumer products company and was formed in 1933 as Lever Brothers India Limited. ... ICICI Bank (formerly Industrial Credit and Investment Corporation of India) is Indias largest private sector bank in market capitalization and second largest overall in terms of assets. ... Infosys Technologies Limited (BSE: 500209, NASDAQ: INFY) is a multinational information technology services company headquartered in Bangalore, India. ... ITC Limited which previously stood for Imperial Tobacco Company of India Limited[1], is one of Indias foremost private sector companies with a market capitalisation of more than US $ 10 billion and a turnover of US $ 3. ... Larsen & Toubro Limited is Indias largest engineering and construction conglomerate, with diverse interests such as construction, hydraulic equipment, electrical and electronic power services, fertilizer projects, medical electronics and information technology. ... Maruti Udyog Limited is a publicly listed Automaker in India. ... National Thermal Power Corporation is the largest power generation company in India. ... Oil and Natural Gas Corporation Limited (ONGC) (incorporated on June 23, 1993) is a public sector petroleum company based in Dehradun, India. ... Ranbaxy Laboratories Limited is an Indian company incorporated in 1961. ... Reliance Communications (formerly Reliance Infocomm), along with Reliance Telecom and Flag Telecom, is part of Reliance Communications Ventures (RCoVL). ... Reliance Energy, formerly known as Bombay Suburban Electric Supply (BSES), is a company under the Reliance - Anil Dhirubhai Ambani Group [1] banner, one of Indias largest conglomerates. ... (NSE: RELIANCE) is Indias largest private sector company with a turnover of US $19. ... Satyam Computer Services Ltd. ... State Bank of India (SBI) (LSE: SBID) is the largest bank in India. ... Tata Consultancy Services Limited (TCS Limited company) is one of the world’s largest providers of information technology, consulting, services and business-process outsourcing which commenced operations in 1968. ... Tata Motors Limited, formerly known as TELCO (TATA Engineering and Locomotive Company), is Indias largest passenger automobile and commercial vehicle manufacturing company. ... Tata Steel, formerly known as TISCO (Tata Iron and Steel Company Limited), is a steel company based in Mumbai, India. ... Wipro Tech (NYSE: WIT) is an information technology service company established in India in 1980. ...
All-time BSE Sensex companies

v • d • e S&P CNX Nifty companies of India

ABB · ACC · Bajaj Auto · BHEL · Bharat Petroleum · Bharti Airtel · Cipla · Dabur · Dr. Reddy's Laboratories · GAIL · GlaxoSmithKline · Grasim Industries · Gujarat Ambuja Cements · HCL Technologies · HDFCHDFC Bank · Hero Honda Motors · Hindalco Industries · HLL · Hindustan Petroleum · ICICI Bank · Indian Petrochemicals · Infosys · Jet Airways · ITC Limited · L&T · MTNL · Mahindra & Mahindra · Maruti Udyog · National Aluminium Company · ONGC · Oriental Bank of Commerce · PNB · Ranbaxy Laboratories · Reliance Communications · Reliance Energy · Reliance Industries · Satyam · Siemens · SBI · SAIL · Sun Pharmaceuticals · Suzlon · TCS · Tata Motors · Tata Power · Tata Steel · VSNL · Wipro · Zee List of BSE Sensex companies provides details of all companies that have been included in the BSE Sensex from its inception in 1986. ... Image File history File links Flag_of_India. ... “Nifty” redirects here. ... The Associated Cement Companies Limited(ACC), an Indian company in cement manufacturing business. ... Bajaj Auto is a major Indian automobile manufacturer. ... BHEL or Bharat Heavy Electricals Limited is a Gas and Steam turbine manufacturer in India. ... Bharat Petroleum Corporation Limited (BPCL) is one of Indias largest PSU companies. ... For the information technology, see Airtel (FBI). ... Cipla is an Indian pharmaceutical company, best-known for manufacturing cheap anti-AIDS drugs. ... Dabur India Limited is the fourth largest FMCG Company in India with interests in Health care, Personal care and Food products. ... GAIL , or GAIL India Limited , erstwhile Gas Authority of India Limited, is one of Indias largest PSU (Public Sector Unit, Youngest Navratna Company. ... // Aditya Birla Group operates over 40 companies in 12 countries across 4 continents. ... Ambuja Cements Limited, formerly known as Gujrat Ambuja Limited is a major Cement producing company in India. ... HCL Technologies is one of the leading global technology and IT enterprises that offers product engineering, technology and application services, BPO, infrastructure services, IT hardware, systems integration, and distribution of technology and telecom products in India. ... HDFC or Housing Development Finance Corporation Limited (founded 1977) is an Indian company which is primarily in the business of providing home loans. ... HDFC Bank logo HDFC Bank (NYSE: HDB), one amongst the firsts of the new generation, tech-savvy commercial banks of India, was set up in august 1994 after the Reserve Bank of India allowed setting up of Banks in the private sector. ... Hero Honda Motors Limited is a Indian two wheeler company. ... Hindalco Industries is one of Indias largest material-related company and is a subsidiary of the Aditya Birla Group. ... Hindustan Lever Limited (also called HLL), headquartered in Mumbai, is Indias largest consumer products company, formed in 1933 as Lever Brothers India Limited. ... Hindustan Petroleum is a petroleum refining enterprise owned by the Govt. ... ICICI Bank (formerly Industrial Credit and Investment Corporation of India) is Indias largest private sector bank in market capitalization and second largest overall in terms of assets. ... Infosys Technologies Limited (BSE: 500209, NASDAQ: INFY) is a multinational information technology services company headquartered in Bangalore, India. ... Jet Airways (India) Ltd. ... ITC Limited which previously stood for Imperial Tobacco Company of India Limited[1], is one of Indias foremost private sector companies with a market capitalisation of more than US $ 10 billion and a turnover of US $ 3. ... Larsen & Toubro Limited is Indias largest engineering and construction conglomerate, with diverse interests such as construction, hydraulic equipment, electrical and electronic power services, fertilizer projects, medical electronics and information technology. ... The Mahanagar Telephone Nigam Limited is the government owned telephone service provider in the cities of Mumbai, Thane, New Delhi and Navi Mumbai in India. ... 1970s domestic market FC-160 Mahindra & Mahindra Limited (M&M) is a major automaker in India. ... Maruti Udyog Limited is a publicly listed Automaker in India. ... National Aluminium Company Limited, abbreviated as NALCO, (incorporated 1981) has units all over India at places like Angul and Damanjodi. ... Oil and Natural Gas Corporation Limited (ONGC) (incorporated on June 23, 1993) is a public sector petroleum company based in Dehradun, India. ... Oriental Bank of Commerce, established on 19th February, 1973, in Lahore (then a city of British India, and currently in Pakistan), is one of the public sector banks in India. ... Punjab National Bank (PNB) is the second largest public sector bank in India with about 4500 branches and offices throughout the country. ... Ranbaxy Laboratories Limited is an Indian company incorporated in 1961. ... Reliance Communications (formerly Reliance Infocomm), along with Reliance Telecom and Flag Telecom, is part of Reliance Communications Ventures (RCoVL). ... Reliance Energy, formerly known as Bombay Suburban Electric Supply (BSES), is a company under the Reliance - Anil Dhirubhai Ambani Group [1] banner, one of Indias largest conglomerates. ... (NSE: RELIANCE) is Indias largest private sector company with a turnover of US $19. ... Satyam Computer Services Limited is a consulting and information technology (IT) services company based in India. ... State Bank of India (SBI) (LSE: SBID) is the largest bank in India. ... Steel Authority of India Limited (SAIL) is the second largest steel maker in India. ... Suzlon Energy is the worlds largest fully-integrated wind power company. ... Tata Consultancy Services Limited (TCS Limited company) is one of the world’s largest providers of information technology, consulting, services and business-process outsourcing which commenced operations in 1968. ... Tata Motors Limited, formerly known as TELCO (TATA Engineering and Locomotive Company), is Indias largest passenger automobile and commercial vehicle manufacturing company. ... The Tata Power Company Limited is India’s largest private sector electricity generating company with an installed generation capacity of over 2300 MW. The Company has emerged as a pioneer in the Indian power sector, with a track record of performance, customer care and sustained growth. ... Tata Steel, formerly known as TISCO (Tata Iron and Steel Company Limited), is a steel company based in Mumbai, India. ... Videsh Sanchar Nigam Ltd (NYSE: VSL, BSE: 500483 , NSE:VSNLEQ) is a global Indian-telecommunications company. ... It has been suggested that this article or section be merged with Wipro Technologies. ... The Zee Network is a television network of satellite channels that consists of Zee TV, Zee Cinema, Zee News, Zee Muzic, Zee Café, Zee Studio, Zee Trendz, Zee Punjabi, Zee Bangla, Zee Gujarati, Zee Marathi, ETC, ETC Punjabi, Zee Action, Zee Smile, Zee Classic, Zee Premiere, Zee Arabiya, Zee Telugu...